Patent application number | Description | Published |
20080234358 | NAPHTHALENE DERIVATIVES - A compound of formula (I) | 09-25-2008 |
20090186867 | Substituted Diketopiperazines As Oxytocin Antagonists - A method of treating or preventing diseases or conditions mediated through the action of oxytocin which comprises administering to a human in need thereof of an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof. | 07-23-2009 |
20090247541 | Novel compounds - Compounds of formula (I) | 10-01-2009 |
20100305127 | NOVEL COMPOUNDS - Compounds of formula (I) | 12-02-2010 |
20110152262 | NOVEL COMPOUNDS - Compounds of formula (I) | 06-23-2011 |
20110257205 | XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS - The present invention relates to compounds which are xanthine derivatives, processes for the manufacture of said derivatives, pharmaceutical formulations containing these compounds and the use of the compounds in therapy, for example, in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial. | 10-20-2011 |
20120202811 | NOVEL COMPOUNDS - Compounds of formula (I) | 08-09-2012 |
20120220779 | Novel Processes - The present invention provides processes useful for preparing 5-lipoxygenase activating protein (FLAP) inhibitors and their intermediates. In particular, processes for preparing 3-[3-(tert-butylsulfanyl)-1-[4-(6-ethoxy-pyridin-3-yl)benzyl]-5-(5-methyl-pyridin-2-yl-methoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid, the anhydrous Form C polymorph of sodium 3-[3-(tert-butylsulfanyl)-1-[4-(6-ethoxy-pyridin-3-yl)benzyl]-5-(5-methyl-pyridin-2-yl-methoxy)-1H-indol-2-yl]-2,2-dimethyl-propionate, and intermediates useful in said processes are provided. | 08-30-2012 |
20130131338 | SUBSTITUTED DIKETOPIPERAZINES AS OXYTOCIN ANTAGONISTS - A method of treating or preventing diseases or conditions mediated through the action of oxytocin which comprises administering to a human in need thereof of an effective amount of a compound of the formula (I) or a pharmaceutically acceptable salt thereof. | 05-23-2013 |
20130253188 | NOVEL COMPOUNDS - Compounds of formula (I) | 09-26-2013 |
20140235639 | NOVEL COMPOUNDS - Compounds of formula (I) | 08-21-2014 |